LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 131

Search options

  1. Article ; Online: Real-life studies and registries of severe asthma: The advent of digital technology.

    Urdova, V / Rogers, L / Jesenak, M / Seys, S F

    Respiratory medicine

    2023  Volume 220, Page(s) 107429

    Abstract: Severe asthma is a chronic and heterogeneous disease that negatively affects the quality of life of our patients and health care utilization. Given the remaining burden of uncontrolled disease in many of these patients, better understanding of its ... ...

    Abstract Severe asthma is a chronic and heterogeneous disease that negatively affects the quality of life of our patients and health care utilization. Given the remaining burden of uncontrolled disease in many of these patients, better understanding of its epidemiology, disease mechanisms, effectiveness of novel therapies such as biologics are still highly needed. Asthma treatment guidelines are largely informed by randomized controlled trials (RCTs) and meta analyses of RCTs, however inclusion criteria of many efficacy RCTs of asthma treatments often exclude a high number of patients with asthma in the community. Data from real-life studies and registries of severe asthma can complement efficacy studies by not only providing evidence on how a treatment performs in everyday clinical practice, post marketing safety information, data to support subsequent clinical trial design, but also helping to delineate the natural history of a disease and supporting important translational research endeavors. In the current review, we summarise available national and international collaborative studies and registries, the variables studies and the novel data and insights they provide. The key source of information for most asthma registries are real-life data from patient's electronic health records. Advent of digital technology in collecting data and their analysis is obvious and we draw attention to generation of new knowledge from registries of severe asthma to improve current diagnostic and therapeutic guidelines and asthma control.
    MeSH term(s) Humans ; Digital Technology ; Asthma/therapy ; Asthma/drug therapy
    Language English
    Publishing date 2023-11-04
    Publishing country England
    Document type Review ; Journal Article
    ZDB-ID 1003348-8
    ISSN 1532-3064 ; 0954-6111
    ISSN (online) 1532-3064
    ISSN 0954-6111
    DOI 10.1016/j.rmed.2023.107429
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Initial use of subcutaneous plasma-derived C1 inhibitor in prophylaxis of acute attacks of hereditary angioedema in pregnant patients in Slovakia.

    Hrubišková, Katarína / Jeseňák, Miloš / Payer, Juraj

    Vnitrni lekarstvi

    2023  Volume 69, Issue 4, Page(s) 265–268

    Abstract: Hereditary angioedema (HAE) is a rare, inborn disease manifested with recurrent attacks of angioedema. They can affect the skin and subcutaneous tissue, mucous membranes (gastrointestinal, respiratory, and uropoietic tracts), and submucous tissue. Women ... ...

    Title translation Prvé použitie podkožného C1 inhibítora v profylaxii atakov hereditárneho angioedému u tehotných pacientok na Slovensku.
    Abstract Hereditary angioedema (HAE) is a rare, inborn disease manifested with recurrent attacks of angioedema. They can affect the skin and subcutaneous tissue, mucous membranes (gastrointestinal, respiratory, and uropoietic tracts), and submucous tissue. Women in reproductive age require specific management of the disease regarding both the course of the disease and treatment options. It is not only the treatment in female patients that is specific, but also the situations (pregnancy, breastfeeding). We present a case report of the initial use of a subcutaneous C1 inhibitor in the long-term prophylaxis of HAE attacks in two pregnant patients.
    MeSH term(s) Pregnancy ; Humans ; Female ; Angioedemas, Hereditary/drug therapy ; Angioedemas, Hereditary/prevention & control ; Subcutaneous Tissue ; Slovakia ; Angioedema
    Language English
    Publishing date 2023-06-09
    Publishing country Czech Republic
    Document type Case Reports ; Journal Article
    ZDB-ID 138213-5
    ISSN 1801-7592 ; 0042-773X
    ISSN (online) 1801-7592
    ISSN 0042-773X
    DOI 10.36290/vnl.2023.050
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Managing T2-high severe asthma in HIV-infected patients.

    Terl, Milan / Jesenak, Milos

    The journal of allergy and clinical immunology. In practice

    2021  Volume 9, Issue 2, Page(s) 1041–1043

    MeSH term(s) Antibodies, Monoclonal, Humanized ; Asthma/epidemiology ; HIV Infections/complications ; HIV Infections/drug therapy ; Humans
    Chemical Substances Antibodies, Monoclonal, Humanized ; mepolizumab (90Z2UF0E52)
    Language English
    Publishing date 2021-02-08
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2020.11.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19.

    Barnova, M / Bobcakova, A / Urdova, V / Kosturiak, R / Kapustova, L / Dobrota, D / Jesenak, M

    Physiological research

    2022  Volume 70, Issue S2, Page(s) S227–S247

    Abstract: COVID-19 (Coronavirus Disease) is an infectious disease caused by the coronavirus SARS-CoV-2 (Severe acute respiratory syndrome Coronavirus 2), which belongs to the genus Betacoronavirus. It was first identified in patients with severe respiratory ... ...

    Abstract COVID-19 (Coronavirus Disease) is an infectious disease caused by the coronavirus SARS-CoV-2 (Severe acute respiratory syndrome Coronavirus 2), which belongs to the genus Betacoronavirus. It was first identified in patients with severe respiratory disease in December 2019 in Wuhan, China. It mainly affects the respiratory system, and in severe cases causes serious lung infection or pneumonia, which can lead to the death of the patient. Clinical studies show that SARS-CoV-2 infection in critical cases causes acute tissue damage due to a pathological immune response. The immune response to a new coronavirus is complex and involves many processes of specific and non-specific immunity. Analysis of available studies has shown various changes, especially in the area of specific cellular immunity, including lymphopenia, decreased T cells (CD3+, CD4+ and CD8+), changes in the T cell compartment associated with symptom progression, deterioration of the condition and development of lung damage. We provide a detailed review of the analyses of immune checkpoint molecules PD-1, TIM-3, LAG-3 CTLA-4, TIGIT, BTLA, CD223, IDO-1 and VISTA on exhausted T cells in patients with asymptomatic to symptomatic stages of COVID-19 infection. Furthermore, this review may help to better understand the pathological T cell immune response and improve the design of therapeutic strategies for patients with SARS-CoV-2 infection.
    MeSH term(s) Animals ; COVID-19/immunology ; COVID-19/metabolism ; COVID-19/virology ; Host-Pathogen Interactions ; Humans ; Immune Checkpoint Proteins/metabolism ; Phenotype ; SARS-CoV-2/immunology ; SARS-CoV-2/pathogenicity ; Signal Transduction ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism
    Chemical Substances Immune Checkpoint Proteins
    Language English
    Publishing date 2022-01-03
    Publishing country Czech Republic
    Document type Journal Article ; Review
    ZDB-ID 1073141-6
    ISSN 1802-9973 ; 0369-9463 ; 0862-8408
    ISSN (online) 1802-9973
    ISSN 0369-9463 ; 0862-8408
    DOI 10.33549/physiolres.934757
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Identification of a novel

    Kolkova, Zuzana / Durdik, Peter / Holubekova, Veronika / Durdikova, Anna / Jesenak, Milos / Banovcin, Peter

    Frontiers in pediatrics

    2024  Volume 12, Page(s) 1339664

    Abstract: Background: The mutations in the : Methods: Two young brothers from a non-consanguineous Slovak family with diagnosed retinal dystrophy and recurrent respiratory infections were examined. Suspected PCD was diagnosed based on a PICADAR questionnaire, ... ...

    Abstract Background: The mutations in the
    Methods: Two young brothers from a non-consanguineous Slovak family with diagnosed retinal dystrophy and recurrent respiratory infections were examined. Suspected PCD was diagnosed based on a PICADAR questionnaire, nasal nitric oxide analysis, transmission electron microscopy, high-speed video microscopy analysis, and genetic testing.
    Results: We identified a novel frameshift
    Conclusion: The identified novel pathogenic mutation in the
    Language English
    Publishing date 2024-01-25
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 2711999-3
    ISSN 2296-2360
    ISSN 2296-2360
    DOI 10.3389/fped.2024.1339664
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Editorial: Definition of the immune parameters related to COVID-19 severity.

    Tincati, Camilla / de Vries, Rory / Jesenak, Milos / Marchetti, Giulia

    Frontiers in immunology

    2023  Volume 14, Page(s) 1204125

    MeSH term(s) Humans ; COVID-19/immunology
    Language English
    Publishing date 2023-04-27
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1204125
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Mild Hyperglycaemia in Hospitalised Children with Moderate COVID-19 Infection.

    Vojtková, Jarmila / Bánovčin, Peter / Ďurdíková, Anna / Nováková, Elena / Jeseňák, Miloš

    Medicina (Kaunas, Lithuania)

    2023  Volume 59, Issue 5

    Abstract: Background and ... ...

    Abstract Background and Objectives
    MeSH term(s) Child ; Humans ; Hyperglycemia/complications ; COVID-19/complications ; Child, Hospitalized ; Prognosis ; Hospitalization
    Language English
    Publishing date 2023-05-14
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2188113-3
    ISSN 1648-9144 ; 1010-660X
    ISSN (online) 1648-9144
    ISSN 1010-660X
    DOI 10.3390/medicina59050944
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Omalizumab in An 8-Year-Old Boy With Diabetes Mellitus and Refractory Chronic Spontaneous Urticaria.

    Jesenak, M / Ciljakova, M / Janickova, M / Banovcin, P

    Journal of investigational allergology & clinical immunology

    2019  Volume 29, Issue 2, Page(s) 144–146

    MeSH term(s) Anti-Allergic Agents/therapeutic use ; Child ; Chronic Disease ; Diabetes Mellitus, Type 1/drug therapy ; Humans ; Male ; Omalizumab/therapeutic use ; Thyroiditis, Autoimmune/drug therapy ; Treatment Outcome ; Urticaria/drug therapy
    Chemical Substances Anti-Allergic Agents ; Omalizumab (2P471X1Z11)
    Language English
    Publishing date 2019-04-24
    Publishing country Spain
    Document type Case Reports ; Journal Article
    ZDB-ID 1128657-x
    ISSN 1018-9068
    ISSN 1018-9068
    DOI 10.18176/jiaci.0351
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Blood eosinophils: In quest of a Holy Grail for personalized asthma treatment with biologicals.

    Jesenak, Milos / Diamant, Zuzana

    Allergy

    2020  Volume 75, Issue 6, Page(s) 1294–1297

    MeSH term(s) Asthma/drug therapy ; Biological Products/therapeutic use ; Eosinophils ; Humans
    Chemical Substances Biological Products
    Language English
    Publishing date 2020-03-31
    Publishing country Denmark
    Document type Editorial
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.14253
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Successful Use of Recombinant Human C1-INH in a Patient with Acquired Angioedema due to C1 Inhibitor Deficiency and an Unusually High Titer of Anti-C1-Inhibitor Autoantibodies.

    Jesenak, M / Brndiarova, M / Banovcin, P / Varga, L / Farkas, H

    Journal of investigational allergology & clinical immunology

    2020  Volume 31, Issue 3, Page(s) 255–256

    MeSH term(s) Aged ; Angioedema/drug therapy ; Angioedema/immunology ; Angioedemas, Hereditary/drug therapy ; Angioedemas, Hereditary/immunology ; Autoantibodies/blood ; Autoantigens/immunology ; Complement C1 Inhibitor Protein/genetics ; Complement C1 Inhibitor Protein/immunology ; Complement C1 Inhibitor Protein/therapeutic use ; Humans ; Immunity, Humoral ; Male ; Recombinant Proteins/genetics
    Chemical Substances Autoantibodies ; Autoantigens ; Complement C1 Inhibitor Protein ; Recombinant Proteins
    Language English
    Publishing date 2020-07-30
    Publishing country Spain
    Document type Case Reports ; Journal Article
    ZDB-ID 1128657-x
    ISSN 1018-9068
    ISSN 1018-9068
    DOI 10.18176/jiaci.0635
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top